Twist Bioscience Corporation TWST Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| DNA synthesis and protein solutions | $53.27M+4.3% | $51.06M+692% | $6.44M+14.8% | $5.61M-86.5% | $41.65M+3.9% | |
| NGS applications | $57.44M+9.1% | $52.64M-0.7% | $53.03M-4.1% | $55.28M+8.1% | $51.15M+5.1% | |
| Revenue by Geography | ||||||
| Americas | $64.31M+10.2% | $58.38M+1.9% | $57.3M-3.5% | $59.39M+7.6% | $55.19M+2.8% | |
| APAC | $9.06M+30.3% | $6.95M-2.9% | $7.16M+20.8% | $5.93M-14.9% | $6.96M+3.9% | |
| EMEA | $37.35M-2.7% | $38.37M+11.0% | $34.55M+12.4% | $30.74M+0.3% | $30.64M+8.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Twist Bioscience Corporation break its business down?
- Twist Bioscience Corporation (TWST) reports revenue by product across 2 parts — DNA synthesis and protein solutions and NGS applications. Each is extracted from the segment footnotes and tracked over time.
- Where does Twist Bioscience Corporation's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Twist Bioscience Corporation's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
